Analysts See Potential 300% upside for Cassava Sciences Despite Controversy
Oct 30, 2024
Alzheimer's Stock Market Invest
Athira Pharma Completes LIFT-AD Trial for Alzheimer's Treatment, Expects Results by Q3 2024
Jul 10, 2024
Cognition Therapeutics Reveals Key Pathways in Alzheimer's and Parkinson's Diseases via Sigma-2 Receptor Modulators
Nov 15, 2023